Genetic polymorphisms of the tumor necrosis factor and lymphotoxin alpha in type 2 diabetes

Rev Med Inst Mex Seguro Soc. 2013 Jan-Feb;51(1):42-9.

Abstract

Objective: To investigate the frequency of the single-base change polymorphic variants identified in tumor necrosis factor (TNF) gene (-308 G/A) and lymphotoxin alpha (LTA) (+252 G/A) in patients with type 2 diabetes (T2D).

Methods: A prospective study in a Mexican-mestizo population of 51 patients with T2D and 48 healthy subjects was carried out. We took a peripheral blood sample from each individual for identification of the polymorphic genotypes by polymerase chain reaction.

Results: The genotype distribution in T2D was: TNF alpha homozygous 0%; TNFG/A heterozygous 20%; TNFG homozygous 80%.

Conclusions: In regards to the TNF -308 G/A genotype, we found a significant difference (p = 0.012) with a bigger frequency in the group of patients. The health controls showed a higher frequency of TNF -308 G/G genotype (p = 0.034).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 2 / genetics*
  • Female
  • Humans
  • Lymphotoxin-alpha / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / genetics*
  • Young Adult

Substances

  • Lymphotoxin-alpha
  • Tumor Necrosis Factor-alpha